Table 1 Baseline characteristics of the study patients.

Age (years)

55.1 ± 10.6

Male sex

99 (80.5%)

Paroxysmal

53 (43.1%)

Congestive heart failure

5 (4.1%)

Hypertension

42 (34.1%)

Diabetes mellitus

10 (8.1%)

Cerebrovascular events

12 (9.8%)

Vascular disease

4 (3.2%)

Baseline LA volume (ml)

101.2 ± 43.3

Baseline LAA volume (ml)

19.4 ± 8.5

Average LAA flow velocity (cm/sec)

41.3 ± 20.8

LV ejection fraction (%)

54.2 ± 6.0

Hemoglobin (g/dl)

14.9 ± 1.3

WBC (×10³/ul)

6.4 ± 1.5

Platelets (×10³/ul)

200.2 ± 39.6

INR

1.4 ± 0.6

Creatinine (mg/dl)

1.0 ± 0.2

CHA₂DS₂-VASc

1.2 ± 1.3

Follow up duration (days)

715.9 ± 227.8

Mean MRI follow up duration (days)

420.5 ± 171.5

Substrate modification

46 (37.4%)

Ablation time (min)

108.4 ± 56.6

Late recurrence

78 (63.4%)